Health score, price, valuation, risk signals, and key metrics at a glance.
Grade capped at D — Interest coverage below 1× (0.9x) — earnings cannot cover interest. Strongest: Growth (18/25); weakest: Balance Sheet & Red Flags (13/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
Operating margins declined 16.2% — watch for continued compression, which may signal competitive or cost pressure.
FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.
as of June 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Shares outstanding increased 33.9% — significant dilution, likely from stock compensation or capital raises.